Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Xeris Pharmaceuticals
Xeris Pharmaceuticals
(XERS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Keveyis
Dichlorphenamide
1982-01-01
Glaucoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Glucagon
healthy volunteers/patients
,
common cold
,
liver failure
,
hepatic insufficiency
,
chronic kidney failure
,
renal insufficiency
,
hyperglycemia
,
chronic renal insufficiency
,
binge-eating disorder
,
type 1 diabetes mellitus
,
hypoglycemia
,
glucose metabolism disorders
,
endocrine system diseases
,
weight loss
,
non-alcoholic fatty liver disease
,
fatty liver
,
left ventricular dysfunction
,
heart failure
,
nutrition disorders
,
obstructive sleep apnea
,
sleep apnea syndromes
,
apnea
,
prediabetic state
,
disease
,
motor activity
,
weight gain
,
ulcerative colitis
,
crohn disease
,
type 2 diabetes mellitus
,
obesity
,
diabetes mellitus
,
overweight
,
metabolic diseases
,
metabolic syndrome
,
body weight
,
coronary artery disease
,
psoriatic arthritis
,
psoriasis
,
myocardial ischemia
,
atherosclerosis
,
knee osteoarthritis
,
osteoarthritis
,
fasting
,
headache
,
pseudotumor cerebri
,
carcinoma
,
thyroid neoplasms
,
neuroendocrine carcinoma
,
papillary thyroid cancer
,
thyroid diseases
,
diabetic nephropathies
,
inflammation
Bevifimod
hematologic neoplasms
,
neoplasms
,
hematologic diseases
,
adenocarcinoma
,
non-hodgkin lymphoma
,
multiple myeloma
,
plasma cell neoplasms
,
mantle-cell lymphoma
,
large b-cell lymphoma diffuse
,
leukemia
,
recurrence
,
extranodal nk-t-cell lymphoma
,
lymphoma
,
t-cell lymphoma
,
hodgkin disease
,
waldenstrom macroglobulinemia
,
b-cell lymphoma
,
large-cell lymphoma anaplastic
,
immunoblastic lymphadenopathy
,
t-cell lymphoma peripheral
Insulin
weight loss
,
type 1 diabetes mellitus
,
diabetes mellitus
,
diabetic neuropathies
,
type 2 diabetes mellitus
,
insulin resistance
,
metabolic syndrome
,
dyslipidemias
,
cerebral palsy
,
hiv infections
,
acquired immunodeficiency syndrome
,
hypertriglyceridemia
,
myocardial ischemia
,
angina pectoris
,
postpartum depression
,
abdominal obesity
,
lipid metabolism
,
inflammation
Viaject
polycystic ovary syndrome
,
hypoglycemia
,
hyperglycemia
,
type 2 diabetes mellitus
,
diabetes mellitus
,
type 1 diabetes mellitus
,
insulin resistance
,
glucose intolerance
,
non-alcoholic fatty liver disease
,
obesity
,
pediatric obesity
,
cardiovascular diseases
,
prediabetic state
,
diabetic neuropathies
Pram9
type 1 diabetes mellitus
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use